How shorted is Oncopeptides AB?
1.38%
of share capital in disclosed short positions · 10 Jul 2026
- 5-day change
- –
- 20-day change
- –
Who is short Oncopeptides AB?
| Position holder | Position | Since |
|---|---|---|
| GSA Capital Partners LLP | 0.81% | 3 Jul 2026 |
| Two Sigma Investments, LP | 0.57% | 3 Jul 2026 |
Named positions of 0.5%+ as published by the Finansinspektionen. The dates shown are each holder's latest disclosure date.
History
| Position date | Short % | Change |
|---|---|---|
| 10 Jul 2026 | 1.38% | – |
Frequently asked questions
- How shorted is Oncopeptides AB right now?
- Disclosed net short positions total 1.38% of Oncopeptides AB's share capital as of 10 Jul 2026, per the Finansinspektionen's public register.
- Who is shorting Oncopeptides AB?
- The Finansinspektionen names each holder of a position of 0.5% or more. Currently disclosed: GSA Capital Partners LLP, Two Sigma Investments, LP.
- What does this number include?
- The sum of individually disclosed net short positions of 0.5% or more of share capital. Positions between 0.1% and 0.5% are reported to the regulator privately and are not public, so the true total can be higher.
- How often is this updated?
- Position holders must disclose changes by the next trading day; we refresh from the Finansinspektionen's register every trading day.